World's Best Scientists 2026 revealed!

D-Index & Metrics

Social Sciences and Humanities

D-Index
48
Citations
7702
World Ranking
3208
National Ranking
30

Overview

Hannu Alho is affiliated with the University of Helsinki in Finland, with a primary research focus on medicine and neuroscience. Their scholarly work encompasses a variety of subfields including epidemiology, cellular and molecular neuroscience, pathology and forensic medicine, public health, environmental and occupational health, and biochemistry.

The research topics covered in their publications include substance abuse treatment and outcomes, neurotransmitter receptor influence on behavior, alcohol consumption and health effects, opioid use disorder treatment, eicosanoids and hypertension pharmacology, poisoning and overdose treatments, and pain management and opioid use.

Alho's publication record features work in several academic venues, with frequent contributions to:

  • Research Square (Research Square)
  • European Journal of Internal Medicine
  • Addictive Behaviors
  • Psychopharmacology Bulletin
  • Alcohol

Recent papers authored or co-authored by Hannu Alho include:

  • Intranasal as needed naloxone in the treatment of gambling disorder: A randomised controlled trial, 2021, Addictive Behaviors

Frequent co-authors in their research collaborations include Bankole A. Johnson, Giovanni Addolorato, Lei Liu, Vinzant Schuyler, and Otto Lesch.

Alho's work addresses substance abuse disorders with a particular emphasis on treatment methods and pharmacotherapy. Their studies investigate the effects of medications such as naloxone and naltrexone in addiction treatments, as well as exploring the pharmacogenetics of low-dose ondansetron in alcohol use disorder.

Their role in advancing knowledge spans diverse aspects of medicine related to both clinical and molecular mechanisms that underpin addiction and its treatment. The interdisciplinary nature of their research integrates epidemiological data with biochemical and neuroscientific perspectives.

Best Publications

  • Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8-hydroxy-2′-deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment

    Marina Erhola;Shinya Toyokuni;Kunihiko Okada;Tomoyuki Tanaka

  • New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus

    Janne Leinonen;Terho Lehtimäki;Shinya Toyokuni;Kunihiko Okada

  • Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial.

    Pekka Heinälä;Hannu Alho;Kalervo Kiianmaa;Jouko Lönnqvist

  • Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users.

    Hannu Alho;David Sinclair;Erkki Vuori;Antti Holopainen

  • Low Plasma Antioxidant Activity Is Associated With High Lesion Volume and Neurological Impairment in Stroke

    Janne S. Leinonen;Jukka-Pekka Ahonen;Kimmo Lönnrot;Mervi Jehkonen

  • Mesolimbic dopamine release is linked to symptom severity in pathological gambling.

    Juho Joutsa;Juho Joutsa;Jarkko Johansson;Solja Niemelä;Antti Ollikainen

  • AUDIT and its abbreviated versions in detecting heavy and binge drinking in a general population survey.

    Mauri Aalto;Hannu Alho;Hannu Alho;Jukka T. Halme;Kaija Seppä

  • Expression of Peripheral-Type Benzodiazepine Receptor and Diazepam Binding Inhibitor in Human Astrocytomas: Relationship to Cell Proliferation

    Helena Miettinen;Juha Kononen;Hannu Haapasalo;Pauli Helén

  • Total antioxidant activity measured by chemiluminescence methods.

    Hannu Alho;Janne Leinonen

  • A RANDOMIZED, MULTICENTRE, OPEN-LABEL, COMPARATIVE TRIAL OF DISULFIRAM, NALTREXONE AND ACAMPROSATE IN THE TREATMENT OF ALCOHOL DEPENDENCE

    E. Laaksonen;A. Koski-Jännes;M. Salaspuro;H. Ahtinen

  • Double-Blind, Randomized Comparison of Memantine and Escitalopram for the Treatment of Major Depressive Disorder Comorbid With Alcohol Dependence

    Leea H Muhonen;Jouko Lönnqvist;Kati Juva;Hannu Alho

  • Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

    Alison D Marshall;Evan B Cunningham;Stine Nielsen;Alessio Aghemo

  • Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus

    Maurice Dematteis;Marc Auriacombe;Oscar D'Agnone;Lorenzo Somaini

  • Magnesium treatment in alcoholics: A randomized clinical trial

    Kari Poikolainen;Hannu Alho

  • Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls

    Pekka Rapeli;Carola Fabritius;Hannu Alho;Mikko Salaspuro

  • Saliva flow rate, amylase activity, and protein and electrolyte concentrations in saliva after acute alcohol consumption

    Nina Enberg;Hannu Alho;Vuokko Loimaranta;Marianne Lenander-Lumikari

  • The alcohol use disorders identification test (AUDIT) and its derivatives in screening for heavy drinking among the elderly

    Mauri Aalto;Hannu Alho;Hannu Alho;Jukka T. Halme;Kaija Seppä

  • Dopamine and Opioid Neurotransmission in Behavioral Addictions: A Comparative PET Study in Pathological Gambling and Binge Eating.

    Joonas Majuri;Joonas Majuri;Juho Joutsa;Juho Joutsa;Jarkko Johansson;Valerie Voon

  • Craving in Opioid Use Disorder : From Neurobiology to Clinical Practice

    Johan Kakko;Hannu Alho;Alexander Mario Baldacchino;Rocio Molina

  • Brief intervention for male heavy drinkers in routine general practice: a three-year randomized controlled study.

    Mauri Aalto;Kaija Seppä;Pekka Mattila;Heikki Mustonen

  • A RANDOMIZED, MULTICENTRE, OPEN-LABEL, COMPARATIVE TRIAL OF DISULFIRAM, NALTREXONE AND ACAMPROSATE IN THE TREATMENT OF ALCOHOL DEPENDENCE.

    E. I. G. Laaksonen;A. Koski-Jännes;H. Ahtiainen;H. Alho

Frequent Co-Authors

Icro Maremmani
Icro Maremmani University of Pisa
Valtteri Kaasinen
Valtteri Kaasinen Turku University Hospital
Juho Joutsa
Juho Joutsa Turku University Hospital
Carlos Roncero
Carlos Roncero University of Salamanca
David A. Sinclair
David A. Sinclair Harvard University
Jeffrey V. Lazarus
Jeffrey V. Lazarus University of Barcelona
Riitta Parkkola
Riitta Parkkola Turku University Hospital
Valerie Voon
Valerie Voon University of Cambridge
Jason Grebely
Jason Grebely University of New South Wales
Gregory J. Dore
Gregory J. Dore University of New South Wales

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students exploring Social Sciences and Humanities in the USA, numerous online degree options offer flexible, accessible pathways to meaningful careers. Counseling and psychology are especially popular choices, opening doors to jobs in mental health, education, and community services.

Those interested in professional counseling can consider cacrep-accredited online counseling programs. Such credentials are highly respected and can lead to licensure in many states. For those aiming to support families and couples, there are several affordable online mft programs focused on marriage and family therapy.

Individuals interested in a foundational social sciences career, such as clinical, research, or organizational roles, may benefit from pursuing an online psychology degree. For those passionate about social work, programs like the easiest msw online program can provide streamlined entry into the profession.

Each pathway offers various levels of affordability and entry requirements, helping learners find the right fit for their educational and career goals in the social sciences and humanities fields.

Best Scientists Citing Hannu Alho

Trending Scientists